Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectal carcinoma identifies patients with good prognosis.

Source:http://linkedlifedata.com/resource/pubmed/id/16485142

Download in:

View as

General Info

PMID
16485142